Prelude Capital Management’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-33,707
Closed -$364K 1160
2022
Q3
$364K Buy
+33,707
New +$364K 0.01% 765